Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-008269
Filing Date
2025-03-18
Accepted
2025-03-18 16:23:13
Documents
2
Period of Report
2025-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3887
2 anwerpoaforedgar.htm EX-24 10582
  Complete submission text file 0001437749-25-008269.txt   16208
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CELSION CORPORATION 997 LENOX DRVIE, SUITE 100 LAWRENCEVILLE NJ 08648
Business Address
Anwer Khursheed (Reporting) CIK: 0001611756 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 25748702